/PRNewswire/ - Summa Silver Corp. ("Summa" or the "Company") (TSXV: SSVR) (OTCQB: SSVRF) (Frankfurt: 48X) is pleased to announce that it is increasing the size.
Thanks to
biotech-focused drug development, the emerging psychedelic industry is stronger than ever before. However, there is a hidden hero in the details of the
numerous press releases pertaining to psychedelic medicine progress – the investment banks allowing this space to grow. Indeed, the sheer scale of psychedelic medicine’s agenda requires a lot of funding, and much of this funding is thanks to investment banks who enter agreements with psychedelic medicine companies. Though there is an obvious mutually beneficial opportunity for both sides of
psychedelic investment, the banks are still taking on a relative area of risk. But by doing so, they are simultaneously making it less risky, more financially stable, and of course, more lucrative for investors.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Skylight Health Group Announces Closing of $13.8 Million Bought Deal Financing
Skylight Health Group Inc.December 30, 2020 GMT
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
TORONTO, Dec. 30, 2020 (GLOBE NEWSWIRE) Skylight Health Group Inc (CSE:SHG; OTCQX: SHGFF) (“SHG” or the “Company”) is pleased to announce it has closed its previously announced bought deal offering of 13,800,000 common shares (the “Common Shares”, each a “Common Share”) in the capital of the Company at a price of C$1.00 per Common Share for aggregate gross proceeds to the Company of C$13,800,000 (the “Offering”), inclusive of the full exercise of the over-allotment option.
Leveljump Healthcare Corp.: Leveljump Health Corp. Announces Closing of Qualifying Transaction
Leveljump Healthcare Corp. (TSXV: GOAL.P) (formerly Good2Go2 Corp.) (
Good2Go2 or the
Company ), is pleased to announce that on December 7, 2020, it closed its previously announced business combination involving Canadian Teleradiology Services, Inc. (
CTS ) as the
Qualifying Transaction of the Company (as such term is defined within the meaning of Policy 2.4 - Capital Pool Companies of the TSX Venture Exchange (the
Exchange )). Subject to receiving final Exchange acceptance, the common shares of the Company are expected to resume trading on the Exchange as a Tier 1 technology issuer on or about December 14, 2020 (the
Leveljump Healthcare Corp. (TSXV:GOAL.P) (formerly Good2Go2 Corp.) (“Good2Go2” or the “Company”), is pleased to announce that on December 7, 2020, it closed its previously announced business combination involving Canadian Teleradiology Services, Inc. (“CTS”) as the “Qualifying Transaction” of the Company (as such term is defined within the meaning of Policy 2.4 – Capital Pool Companies of the TSX Venture Exchange (the “Exchange”))
Leveljump Healthcare Corp. (TSXV:GOAL.P) (formerly Good2Go2 Corp.) (“Good2Go2” or the “Company”), is pleased to announce that on December 7, 2020, it closed its previously announced business combination involving Canadian Teleradiology Services, Inc. (“CTS”) as the “Qualifying Transaction” of the Company (as such term is defined within the meaning of Policy 2.4 – Capital Pool Companies of the TSX Venture Exchange (the “Exchange”)). Subject to receiving final Exchange acceptance, the common shares of the Company a